Status:
COMPLETED
Study of Pain Control in Diagnostic Hysteroscopy
Lead Sponsor:
Phramongkutklao College of Medicine and Hospital
Conditions:
Pain, Postoperative
Eligibility:
FEMALE
20+ years
Phase:
NA
Brief Summary
The goal of this clinical trial study is to learn about how to decrease the pain during the diagnostic hysteroscopy. The main question it aims to answer is "Do the Paracetamol and Ibuprofen taken befo...
Detailed Description
After the participants those are indicated for diagnostic hysteroscopy and eligible for the study undergo informed consent, then they were divided to two groups for control group those get no medicati...
Eligibility Criteria
Inclusion
- Women with indication and informed to undergo diagnostic hysteroscopy over or equal the age of 20 years old
Exclusion
- Women with contraindication for undergoing diagnostic hysteroscopy includes women with pregnancy, uterine infection, diagnosed with cervical cancer or endometrium cancer and women who is undergoing with active vaginal bleeding
- Women with history of allergy to Paracetamol or Ibuprofen medicine
- Women with currently or pre-existing medical conditions that contraindicate the use of ibuprofen includes kidney disease, heart disease, cirrhosis, gastritis or individuals with a history of peptic ulcer or gastrointestinal bleeding
- Women with currently taking anticoagulant or antiplatelet medications
- Women with history of psychiatric disorders
Key Trial Info
Start Date :
December 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 22 2023
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT06188143
Start Date
December 22 2022
End Date
June 22 2023
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Phramongkutklao College of Medicine and Hospital
Bangkok, Thailand, 10400